Generics 16

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Vinblastine sulfate manufacturers

16 products found

Filters

Filters

Filters , active

Country of origin : Kazakshan

Clear all

16 products found

vinblastine sulfate

Solution for injection 1mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #557

Manufacturer usually replies in 6 days

vinblastine sulfate

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

vinblastine sulfate

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510

Manufacturer usually replies in 2 days

vinblastine sulfate

Injection 10 mg/ml, 50 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19783

Manufacturer usually replies in 2 days

vinblastine sulfate

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

vinblastine sulfate

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

vinblastine sulfate

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #20956
It is specialized in the human healthcare field, and has been manufacturing, marketing, and selling pharmaceutical products since the 1980s. They have a broad range of products from OTC, ETC including about 30 kinds of anti-cancer products.

Manufacturer usually replies in 8 days

vinblastine sulfate

Vials, injection 10mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply
Manufacturer #10323

Manufacturer usually replies in 5 days

vinblastine sulfate

Injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

vinblastine sulfate

Solution for injection Upon request

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #17642
This is a known company that operates in the wholesale trade of pharmaceutical products for human as well as veterinary use. The company's portfolio includes high-quality drugs that combine with the best of its return and output at the same time.

Manufacturer usually replies in 9 days

vinblastine sulfate

Solution for injection/infusion 10mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147

Manufacturer usually replies in 7 days

vinblastine sulfate

Injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20801

Manufacturer usually replies in 11 days

vinblastine sulfate

Injection 1 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #1356

vinblastine sulfate

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19912

Manufacturer usually replies in 18 days

vinblastine sulfate

Vials, lyophilized injection 5 mg, 10 mg - 0.5 ml, 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #31067

vinblastine sulfate

Vials, injection 1 mg/1 ml, 5 mg/5 ml, 10 mg/10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30830

Vinblastine sulphate:

Vinblastine (VBL), also commonly known by the brand name of Velban, is a medication used in chemotherapy treatments. It is typically used as part of a combination therapy along with other drugs, where it is used to treat various cancer types including Hodgkin's lymphoma, non-small cell lung cancer, bladder cancer, brain cancer, melanoma, and testicular cancer. It is administered by way of intravenous injection and was originally developed by a pharmaceutical products manufacturing company in 1958. Vinblastine is an example of a natural herbal remedy that has since been developed into a conventional medicine, being originally isolated from the Madagascar periwinkle.

Currently, it has found widespread use in the oncology space, with vinblastine manufacturers and vinblastine suppliers listing it for sale. Where it can be found on the wholesale pharmaceutical products list of distributors on the global marketplace, at a wide array of cost and price points. This is spurred by vinblastine being on the World Health Organization's List of Essential Medicines, indicating it as a cost-effective and efficient medication recommended for use in health systems across the globe.

Method of action of vinblastine sulphate:

Vinblastine belongs to a group of drugs which display antitumor properties. This is enabled due to its ability to inhibit mitosis at the metaphase stage through its interaction with tubulin. As tubulin is a vital cellular structure required for proper division, vinblastine binding to the microtubular proteins of the mitotic spindle and its subsequent crystallization of the microtubule leads to mitotic arrest and prompt cell death.

Form and dosage of vinblastine sulphate:

The final form and packaging of vinblastine is dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, vinblastine can typically be found wholesale in forms including a solution for injection, solution for injection/infusion, vials, and ampules. Vinblastine is a specialised mediation. As such, it is only to be administered by an accredited healthcare professional who will determine the dose and treatment length based on patient-specific factors. It should be noted that vinblastine is only for intravenous administration as inadvertent intrathecal administration risks severe neurotoxicity, which is predominantly fatal. For further information and please refer to the manufacturers’ literature or contact a healthcare professional.

Vinblastine sulphate on Pipelinepharma:

Currently, at the time of writing, we have found 2 verified vinblastine sulphate manufacturers and vinblastine sulphate suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in various countries including Lebanon and India. Each company and their pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of vinblastine sulphate and how to buy:

A cursory search online reveals an approximate wholesale cost to be £85.00 for 1 mg per 1 ml of vinblastine sulphate in 5 ml vial form. This indicated value is only for one specific drug form and an exclusive price for the NHS in the UK. As such they are only intended to serve as a generalization of the current market conditions in a specific area.

Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence.